Home > Boards > US Listed > Telecommunications Hardware > Terayon Communication Systems (TERN)

Still holding and waiting for that White Knight

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
followinsnsr Member Profile
 
Followed By 2
Posts 790
Boards Moderated 0
Alias Born 12/14/05
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/19/2022 4:11:00 PM
Terns Pharmaceuticals Appoints Jeffrey R. Jasper, Ph.D., as Senior Vice President, Head of Research and Promotes Diana Chung to Senior Vice President, Chief Development Officer GlobeNewswire Inc. - 1/6/2022 7:05:00 AM
Terns Pharmaceuticals to Present at 40th Annual J.P. Morgan Health Care Conference GlobeNewswire Inc. - 1/3/2022 4:05:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/15/2021 4:58:55 PM
Terns Pharmaceuticals EPS beats by $0.13 Seeking Alpha - 11/15/2021 4:53:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 4:38:18 PM
Terns Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Highlights GlobeNewswire Inc. - 11/15/2021 4:05:00 PM
Terns Pharmaceuticals Highlights Positive Clinical Data from Multiple NASH Programs at AASLD The Liver Meeting® Digital Experience 2021 GlobeNewswire Inc. - 11/12/2021 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2021 4:55:02 PM
Terns Reports Positive Top-line Results from Phase 1 Proof of Concept Clinical Trial of THR-β agonist TERN-501 GlobeNewswire Inc. - 11/9/2021 4:05:00 PM
Terns Pharmaceuticals to Present Positive Clinical Data on NASH Programs at AASLD The Liver Meeting® Digital Experience 2021 GlobeNewswire Inc. - 10/18/2021 4:05:00 PM
Terns Pharmaceuticals to Present at H.C. Wainwright 5th Annual NASH Investor Conference GlobeNewswire Inc. - 10/5/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/29/2021 6:03:47 AM
Terns Appoints Veteran Biopharmaceutical Executive Ann E. Taylor, M.D. to Board of Directors GlobeNewswire Inc. - 9/28/2021 4:05:00 PM
Goldman Sachs Sees These 2 Stocks Surging Over 70% TipRanks - 9/15/2021 6:07:42 PM
Terns Completes Part 1 Enrollment of AVIATION Phase 1b NASH Clinical Trial of VAP-1 Inhibitor TERN-201 GlobeNewswire Inc. - 9/8/2021 7:05:00 AM
Terns Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 9/2/2021 4:05:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2021 4:44:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2021 4:26:04 PM
Terns Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights GlobeNewswire Inc. - 8/16/2021 4:05:00 PM
Terns Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 8/3/2021 4:05:00 PM
Terns Pharmaceuticals doses first patient in early-stage TERN-201 NASH study Seeking Alpha - 6/24/2021 4:11:37 PM
Terns Announces Initiation of Patient Dosing in AVIATION Phase 1b NASH Clinical Trial of VAP-1 Inhibitor TERN-201 GlobeNewswire Inc. - 6/24/2021 4:05:00 PM
Terns Pharmaceuticals up 9% on positive phase 2 NASH data Seeking Alpha - 6/14/2021 8:42:34 AM
Terns Pharma gains 9% on positive TERN-101 data in mid-stage NASH study Seeking Alpha - 6/14/2021 8:12:23 AM
followinsnsr   Thursday, 06/07/07 08:10:56 PM
Re: None
Post # of 329 
Still holding and waiting for that White Knight to come along.
Seabass, any truth to the rumor you were the lead plaintiff and winner in the class action lawsuit against Terayon?

"There is no great honor these days in being a long (very long).......
Not a lot of profit either it seems."
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences